BeStock  
Markets › Compare › DNTH vs BLTE

DNTH vs BLTE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
DNTH · Dianthus Therapeutics$84.55 ▼ 0.33%
BLTE · Belite Bio$127.38 ▼ 15.65%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

72123174225276Nov 24, '25May 26, '26Nov 20, '26
  • DNTH +93.6%
  • BLTE -6.3%

Head to head

MetricDNTHBLTE
Price$84.55$127.38
Change today▼ 0.33%▼ 15.65%
Market cap$4.76B$5.17B
Return, 3 months-23.2%-19.8%
Return, year to date+105.2%-20.4%
Return, 1 year+104.0%+5.7%
P/E (TTM)––
P/B3.86.7
P/E percentile vs own 5y6th40th
Dividend yield––
Revenue growth (YoY, latest qtr)+205.6%–
Net profit growth (YoY)-26.9%-39.6%
Gross margin––
Operating margin-8,683.9%–
Net margin-7,436.5%–
Return on equity-22.6%-21.2%
Analyst target vs. price+59.2%+81.9%
Analyst buy share100%100%
RSI (14)4732
30-day volatility43.9%74.4%
Max drawdown, 1 year-37.8%-34.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BLTE is the largest of the group by market value.
  • DNTH has returned the most over the past year.
  • DNTH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top